We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-3.55%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$16B
AUM Growth
-$1.4B
Cap. Flow
-$442M
Cap. Flow %
-2.77%
Top 10 Hldgs %
29.19%
Holding
720
New
51
Increased
199
Reduced
358
Closed
49

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$121M
2
ONC
BeOne Medicines Ltd
ONC
+$66.8M
3
ISRG icon
Intuitive Surgical
ISRG
+$56.6M
4
WELL icon
Welltower
WELL
+$48.8M
5
CRDO icon
Credo Technology Group
CRDO
+$45.3M

Top Sells

Rank Stock Value
1
ALTR
Altair Engineering Inc
ALTR
+$67M
2
UNH icon
UnitedHealth
UNH
+$44.7M
3
APH icon
Amphenol
APH
+$43.9M
4
BDX icon
Becton Dickinson
BDX
+$36.4M
5
LLY icon
Eli Lilly
LLY
+$36.1M

Sector Composition

Rank Sector Weight
1 Technology 31.51%
2 Healthcare 25.4%
3 Financials 11.6%
4 Consumer Discretionary 7.99%
5 Industrials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COST icon
76
Costco
COST
$429B
$53.3M 0.33%
56,353
-2,100
-4% -$2.05M
MRVL icon
77
Marvell Technology
MRVL
$157B
$53.3M 0.33%
865,407
+10,039
+1% +$974K
XYL icon
78
Xylem
XYL
$29.7B
$52.6M 0.33%
440,711
-227,973
-34% -$28.3M
INCY icon
79
Incyte
INCY
$26B
$52.6M 0.33%
868,545
-166,107
-16% -$11.6M
ROK icon
80
Rockwell Automation
ROK
$52.4B
$51.9M 0.32%
200,774
-5,689
-3% -$1.58M
AMAT icon
81
Applied Materials
AMAT
$378B
$50.8M 0.32%
349,841
-100,463
-22% -$16.9M
NFLX icon
82
Netflix
NFLX
$301B
$50.1M 0.31%
537,040
-31,220
-5% -$2.97M
JNJ icon
83
Johnson & Johnson
JNJ
$643B
$49.6M 0.31%
299,114
+22,060
+8% +$3.45M
DGX icon
84
Quest Diagnostics
DGX
$26B
$47.1M 0.3%
278,656
+110,946
+66% +$18.2M
FISV
85
Fiserv Inc
FISV
$28.9B
$46.6M 0.29%
211,206
+5,247
+3% +$1.15M
OTIS icon
86
Otis Worldwide
OTIS
$28B
$46.5M 0.29%
450,128
-50,952
-10% -$4.98M
MPWR icon
87
Monolithic Power Systems
MPWR
$63B
$44.5M 0.28%
76,651
+25,859
+51% +$16.3M
ALL icon
88
Allstate
ALL
$70.1B
$43.2M 0.27%
208,509
+99,471
+91% +$19.4M
BMRN icon
89
BioMarin Pharmaceuticals
BMRN
$12B
$43M 0.27%
607,862
+27,640
+5% +$1.86M
PNC icon
90
PNC Financial Services
PNC
$100B
$42.9M 0.27%
243,980
+2,388
+1% +$451K
BSX icon
91
Boston Scientific
BSX
$68.5B
$42.1M 0.26%
414,812
+23,054
+6% +$2.32M
PFE icon
92
Pfizer
PFE
$144B
$42.1M 0.26%
1,659,600
+1,237,099
+293% +$32.4M
WCN
93
Waste Connections
WCN
$42.7B
$40.1M 0.25%
205,685
-108,894
-35% -$20.2M
XOM icon
94
ExxonMobil
XOM
$634B
$39.5M 0.25%
332,097
-1,164
-0.3% -$129K
ASND icon
95
Ascendis Pharma A/S
ASND
$16.7B
$37.8M 0.24%
242,761
-37,393
-13% -$5.34M
NBIX icon
96
Neurocrine Biosciences
NBIX
$18.4B
$36.6M 0.23%
330,840
+26,868
+9% +$3.4M
PH icon
97
Parker-Hannifin
PH
$125B
$36.3M 0.23%
59,701
+355
+0.6% +$232K
KO icon
98
Coca-Cola
KO
$380B
$35.7M 0.22%
498,338
+13,335
+3% +$891K
MTD icon
99
Mettler-Toledo International
MTD
$28.1B
$35.4M 0.22%
29,948
+16,584
+124% +$21.2M
TMUS icon
100
T-Mobile US
TMUS
$196B
$34.7M 0.22%
130,266
+57,033
+78% +$14.1M
2 3
4
5 6

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2025 Portfolio in Review

As of Q1 2025, Candriam SCA held 720 positions worth $16B, down 8.1% from $17.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Candriam SCA's Q1 2025 filing shows 51 new, 199 increased, 358 reduced and 49 closed positions. Its largest new stake was BeOne Medicines Ltd: 285,893 shares worth $77.8M. The largest sale was Altair Engineering Inc, an estimated $67M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q1 2025 buy was BeOne Medicines Ltd: 285,893 shares worth $77.8M.
  • Candriam SCA added most to Meta Platforms (Facebook) in Q1 2025, an estimated $121M increase.
  • Candriam SCA's biggest Q1 2025 reduction was UnitedHealth, cutting an estimated $44.7M.
  • Candriam SCA fully exited Altair Engineering Inc in Q1 2025, selling an estimated $67M.
  • Candriam SCA's ten largest holdings make up 29% of its $16B portfolio in Q1 2025.
  • Candriam SCA opened 51 new positions and closed 49 in Q1 2025.
  • Candriam SCA's portfolio value fell 8.1% quarter-over-quarter to $16B.

Based on Candriam SCA's 13F filing for Q1 2025, filed 14 May 2025.